| 1 |
Heme-Iron Optifer Versus Intravenous Iron/Ferosac in Treatment of Iron Efficiency Anemia During Pregnancy |
|
| | Ibrahim A. Abdelazim,Svetlana Shikanova,Bakyt Karimova,Mukhit Sarsembayev,Gulmira Mukhambetalyeva | | | SN Comprehensive Clinical Medicine. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor |
|
| | Sakiyeva Kanshaiym,Gulmira Zhurabekova,Ibrahim A. Abdelazim,Tatyana Starchenko | | | Hematology, Transfusion and Cell Therapy. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis |
|
| | Adam K. Lewkowitz,Anjlie Gupta,Laura Simon,Bethany A. Sabol,Carrie Stoll,Emily Cooke,Roxanne A. Rampersad,Methodius G. Tuuli | | | Journal of Perinatology. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy |
|
| | Ibrahim A. Abdelazim,Bassam Nusair,Shikanova Svetlana,Gulmira Zhurabekova | | | Archives of Gynecology and Obstetrics. 2018; | | | [Pubmed] [Google Scholar] [DOI] | |
|
